MedPath

Quadripolar CRT-D On Currently Approved Lead SystemS

Completed
Conditions
Heart Failure
Registration Number
NCT02232984
Lead Sponsor
Boston Scientific Corporation
Brief Summary

The purpose of the study is to evaluate different ways to program around extracardiac stimulation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
749
Inclusion Criteria
  • Subject is medically indicated for implantation with a Boston Scientific (BSC) DYNAGEN or INOGEN X4 CRT-D (or any future FDA approved BSC X4 CRT-D) and already implanted with/scheduled to receive a commercially available quadripolar left ventricular lead
  • Subject is willing and capable of providing informed consent and participating in all testing and study visits associated with this investigation at an approved center and at the intervals defined by this protocol
  • Subject is age 18 or above, or of legal age to give informed consent specific to state and national law
Exclusion Criteria
  • Subject has a known or suspected sensitivity to dexamethasone acetate (DXA)
  • Subject is enrolled in any other concurrent study, without prior approval from BSC
  • Women of childbearing potential who are or might be pregnant at the time of study enrollment

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of Vectors With Phrenic Nerve Stimulation (PNS)Pre-discharge (up to 7 days post implant)

The primary objective of this study was to characterize the performance of Boston Scientific (BSC) unique pacing vectors vs. BSC/St Jude Medical (STJ) common pacing vectors to prevent phrenic nerve stimulation (PNS) based on the selected pacing cathode. BSC unique vectors are those that are only available with Boston Scientific's (BSC) quadripolar (X4) CRT-Ds while common vectors are those that are available for both BSC and STJ systems.

Secondary Outcome Measures
NameTimeMethod
Final LV Lead Impedance at Pre-dischargePre-discharge (up to 7 days post implant)

Characterize the electrical performance of BSC pacing vectors using impedance measurements. Summary Statistics Were Provided for LV Tip 1 to LV Ring 2 Measurements. The electrical measurements were taken using the implanted pulse generator (PG) per standard practice.

Final Pacing Treshold at Pre-dischargePre-discharge (up to 7 days post implant)

Characterize the electrical performance of BSC pacing vectors using pacing thresholds. Summary statistics for LV Tip1 to LV Ring 2 pacing thresholds for the BSC pacing vectors were reported. The electrical measurements were taken using the implanted pulse generator (PG) per standard practice.

Final Sensing Amplitude at Pre-dischargePre-discharge (up to 7 days post implant)

Characterize the electrical performance of BSC pacing vectors using sensing amplitudes. Summary statistics were provided for LV Tip 1 to LV Ring 2 measurements. The electrical measurements were taken using the implanted pulse generator (PG) per standard practice.

Delivery System Comparison Between ACUITY Pro and the Other Delivery SystemsAt time of implantation (0 to 30 days post consent signature)

Characterize the performance of the BSC ACUITY Pro delivery system versus competitive delivery systems in the placement of LV leads. Data collected on the use of the ACUITY Pro delivery system and competitive systems were characterized by presenting summary statistics by system (all competitive devices maybe combined for purposes of reporting), and differences between the ACUITY Pro system and competitive systems were reported as appropriate.

Trial Locations

Locations (60)

Mercy Gilbert Medical Center

🇺🇸

Gilbert, Arizona, United States

Phoenix Cardiovascular Research Group/ Heart & Vascular Center of Arizona

🇺🇸

Phoenix, Arizona, United States

St. Joseph's Hospital

🇺🇸

Phoenix, Arizona, United States

Yuma Regional Medical Center

🇺🇸

Yuma, Arizona, United States

Cardiology Associates of Northeast Arkansas

🇺🇸

Jonesboro, Arkansas, United States

Central Arkansas Veterans Healthcare System

🇺🇸

Little Rock, Arkansas, United States

Comprehensive Cardiovascular Medical Group

🇺🇸

Bakersfield, California, United States

Cardiac Device Rhythm Specialists, Inc

🇺🇸

Los Angeles, California, United States

Desert Heart Rhythm

🇺🇸

Palm Springs, California, United States

Bradenton Cardiology Center

🇺🇸

Bradenton, Florida, United States

Scroll for more (50 remaining)
Mercy Gilbert Medical Center
🇺🇸Gilbert, Arizona, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.